Dr. Navile Aditya Murali Medical Oncologist in Faridabad

Dr. Navile Aditya Murali

Medical Oncologist, Faridabad

MBBS, MD (Medicine), DM (Medical Oncology)

  • 1 Hospital

About


  • Languages : English, Hindi, Kannada, Tamil

Experience

Medical Oncology, Adyar Cancer Institute, Chennai

Medical Oncology, Madurai Medical College, Madurai

Specialities

  • Medical Oncology

  • Bone Marrow Transplant

  • Hemato Oncology

Conditions

  • Lung Cancer

Education

MBBS, Kasturba Meical College, India

MD (Medicine), Madurai Medical College, India

DM (Medical Oncology), Cancer Institute (WIA), India

Practice Information

Sarvodaya Hospital & Research Centre, Faridabad

Sarvodaya Hospital & Research Centre, Faridabad

YMCA Road, Sector-8, Near ESI Hospital, Sector-8, Faridabad, Haryana - 121005

Achievements & Contributions

  • Murali N.A, Ganesan P, Vijaykumar V, Kannan K, Radhakrishnan V, Ganesan T.S, Sagar T.G. – Increasing incidence of multi-drug resistant Gram negative septicemia during induction therapy of acute myeloid leukemia. J Hosp Infect [Internet]. [cited 2016 May 9]; Available from: http://dx.doi.org/10.1016/j.jhin.2016.04.012.
  • Murali N.A, Rajendranath R, Ganesan P, Radhakrishnan V, Ganesan T.S, Sagar T.G. Outcomes in Small Cell  Lung cancer in India - A 15 year retrospective analysis. Poster presentation at the 16th World Lung Cancer Congress - 2015 Denver, USA.
  • Murali N.A, Ganesan P, Kannan K, Radhakrishnan V, Ganesan T.S, Sagar T.G. Outcomes in Multiple Myeloma - post high dose chemotherapy and autologous bone marrow transplantation at Cancer Institute. Poster presentation at HEMATOCON 2015 – Banglore
  • Murali N.A, Ganesan P, Vijaykumar V, Kannan K, Radhakrishnan V, Ganesan T.S, Sagar T.G. Carbapenem resistant MDR sepsis during induction chemotherapy in Acute Myeloid Leukemia - Outcome analysis at Cancer Institute. Poster presentation at HEMATOCON 2015 – Banglore-2005.
  • European Society of Medical Oncology
  • International Association for the study of Lung cancer
-->